Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kluza, J.
Right arrow Articles by Bailly, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kluza, J.
Right arrow Articles by Bailly, C.
[Cancer Research 60, 4077-4084, August 1, 2000]
© 2000 American Association for Cancer Research


Biochemistry and Biophysics

Apoptotic Response of HL-60 Human Leukemia Cells to the Antitumor Drug TAS-1031

Jérôme Kluza, Amélie Lansiaux, Nicole Wattez, Christine Mahieu, Neil Osheroff and Christian Bailly2

INSERM U-524 and Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Lille 59045, France [J. K., A. L., N. W., C. M., C. B.], and Vanderbilt University, School of Medicine, Nashville, Tennessee 37232-0146 [N. O.]

TAS-103 is a DNA intercalating indeno-quinoline derivative that stimulates DNA cleavage by topoisomerases. This synthetic drug has a broad spectrum of antitumor activity against many human solid tumor xenografts and is currently undergoing clinical trials. We investigated the induction of apoptosis in human promyelocytic leukemia cells treated with TAS-103. The treatment of proliferating human leukemia cells for 24 h with various concentrations of the drug induces significant variations in the mitochondrial transmembrane potential ({Delta}{Psi}mt) measured by flow cytometry using the fluorochromes 3,3-dihexyloxacarbocyanine iodide, Mitotracker Red, and tetrachloro-tetraethylbenzimidazolcarbocyanine iodide. The collapse of {Delta}{Psi}mt is accompanied by a marked decrease of the intracellular pH. Cleavage experiments with the substrates N-acetyl-Asp-Glu-Val-Asp-pNA, poly(ADP-ribose) polymerase, and pro-caspase-3 reveal unambiguously that caspase-3 is a key mediator of the apoptotic pathway induced by TAS-103. Caspase-8 is also cleaved, and the bcl-2 oncoprotein is underexpressed. Drug-induced internucleosomal DNA fragmentation and the externalization of phosphatidylserine residues in the outer leaflet of the plasma membrane were also characterized. The cell cycle perturbations produced by TAS-103 can be connected with the changes in {Delta}{Psi}mt. At low concentrations (2–25 nM), the drug induces a marked G2 arrest and concomitantly provokes an increase in the potential of mitochondrial membranes. In contrast, treatment of the HL-60 cells with higher drug concentrations (50 nM to 1 µM) triggers massive apoptosis and a collapse of {Delta}{Psi}mt that is a signature for the opening of the mitochondrial permeability transition pores. The discovery of a correlation between the G2 arrest and changes in mitochondrial membrane potential provides an important mechanistic insight into the action of TAS-103.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Yoshida, Y. Kabe, T. Wada, A. Asai, and H. Handa
A New Mechanism of 6-((2-(Dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one Dihydrochloride (TAS-103) Action Discovered by Target Screening with Drug-Immobilized Affinity Beads
Mol. Pharmacol., March 1, 2008; 73(3): 987 - 994.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Intasai, S. Mai, W. Kasinrerk, and C. Tayapiwatana
Binding of multivalent CD147 phage induces apoptosis of U937 cells
Int. Immunol., July 1, 2006; 18(7): 1159 - 1169.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Zhang, J. Wada, I. Hashimoto, J. Eguchi, A. Yasuhara, Y. S. Kanwar, K. Shikata, and H. Makino
Therapeutic Approach for Diabetic Nephropathy Using Gene Delivery of Translocase of Inner Mitochondrial Membrane 44 by Reducing Mitochondrial Superoxide Production
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1090 - 1101.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Matsuoka, J. Wada, I. Hashimoto, Y. Zhang, J. Eguchi, N. Ogawa, K. Shikata, Y. S. Kanwar, and H. Makino
Gene Delivery of Tim44 Reduces Mitochondrial Superoxide Production and Ameliorates Neointimal Proliferation of Injured Carotid Artery in Diabetic Rats
Diabetes, October 1, 2005; 54(10): 2882 - 2890.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Torigoe, H. Izumi, T. Wakasugi, I. Niina, T. Igarashi, T. Yoshida, I. Shibuya, K. Chijiiwa, K.-i. Matsuo, H. Itoh, et al.
DNA Topoisomerase II Poison TAS-103 Transactivates GC-Box-dependent Transcription via Acetylation of Sp1
J. Biol. Chem., January 14, 2005; 280(2): 1179 - 1185.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. C. Chen, X. Zhang, T. P. Singleton, and F. L. Kiechle
Mitochondrial Membrane Potential Change Induced by Hoechst 33342 in Myelogenous Leukemia Cell Line HL-60
Ann. Clin. Lab. Sci., October 1, 2004; 34(4): 458 - 466.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. KLUZA, A. M. CLARK, and C. BAILLY
Apoptosis Induced by the Alkaloid Sampangine in HL-60 Leukemia Cells: Correlation between the Effects on the Cell Cycle Progression and Changes of Mitochondrial Potential
Ann. N.Y. Acad. Sci., December 1, 2003; 1010(1): 331 - 334.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Lansiaux, F. Tanious, Z. Mishal, L. Dassonneville, A. Kumar, C. E. Stephens, Q. Hu, W. D. Wilson, D. W. Boykin, and C. Bailly
Distribution of Furamidine Analogues in Tumor Cells: Targeting of the Nucleus or Mitochondria Depending on the Amidine Substitution
Cancer Res., December 15, 2002; 62(24): 7219 - 7229.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Pang, S. Wakabayashi, and M. Shigekawa
Expression of Calcineurin B Homologous Protein 2 Protects Serum Deprivation-induced Cell Death by Serum-independent Activation of Na+/H+ Exchanger
J. Biol. Chem., November 8, 2002; 277(46): 43771 - 43777.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Facompre, C. Carrasco, P. Colson, C. Houssier, J. D. Chisholm, D. L. Van Vranken, and C. Bailly
DNA Binding and Topoisomerase I Poisoning Activities of Novel Disaccharide Indolocarbazoles
Mol. Pharmacol., November 1, 2002; 62(5): 1215 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Torigoe, H. Izumi, H. Ishiguchi, H. Uramoto, T. Murakami, T. Ise, Y. Yoshida, M. Tanabe, M. Nomoto, H. Itoh, et al.
Enhanced Expression of the Human Vacuolar H+-ATPase c subunit Gene (ATP6L) in Response to Anticancer Agents
J. Biol. Chem., September 20, 2002; 277(39): 36534 - 36543.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Mizutani, S. Tada-Oikawa, Y. Hiraku, S. Oikawa, M. Kojima, and S. Kawanishi
Mechanism of Apoptosis Induced by a New Topoisomerase Inhibitor through the Generation of Hydrogen Peroxide
J. Biol. Chem., August 16, 2002; 277(34): 30684 - 30689.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Lansiaux, M. Facompre, N. Wattez, M.-P. Hildebrand, C. Bal, D. Demarquay, O. Lavergne, D. C. H. Bigg, and C. Bailly
Apoptosis Induced by the Homocamptothecin Anticancer Drug BN80915 in HL-60 Cells
Mol. Pharmacol., September 1, 2001; 60(3): 450 - 461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.